35 results
8-K
EX-1.1
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Other Events
4:30pm
or, to the Company’s knowledge after reasonable investigation and due diligence inquiry (“Knowledge”), contemplated by governmental or regulatory authorities … research or is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result
S-3
EX-1.2
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Shelf registration
9:08am
, inquiry or investigation brought by or before any legal or governmental entity now pending or, to the knowledge of the Company, threatened, against … , investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries and (iv) there are no events or circumstances
S-3
EX-4.4
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Shelf registration
9:08am
shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report … discretion, may make such further inquiry or investigation into such facts or matters as it may see fit.
(h) The Trustee shall not be deemed to have
8-K
EX-1.1
PRAX
Praxis Precision Medicines Inc
12 Jan 24
Other Events
5:23pm
; and no such proceedings are threatened or, to the Company’s knowledge after reasonable investigation and due diligence inquiry (“Knowledge”), contemplated … health care program or human clinical research or is subject to a governmental inquiry, investigation, proceeding, or other similar action that could
8-K
EX-1.1
rrepw catm3vhpy8
7 Dec 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-1.1
0zir5 5alypcb
20 Jun 23
Other Events
7:02am
8-K
EX-3.1
gei 1dxsybg9p7k
7 Jan 22
Amendments to Articles of Incorporation or Bylaws
4:09pm
S-3ASR
EX-1.2
6nsoyy mgkc6xfhiu0
3 Nov 21
Automatic shelf registration
5:08pm
S-3ASR
EX-4.3
xx7 z46mw1reyn92pp5z
3 Nov 21
Automatic shelf registration
5:08pm
8-K
EX-99.1
136bxmv
3 Nov 21
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results
7:04am
8-K
EX-99.1
z29i6
16 Aug 21
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2021 Financial Results
8:04am
8-K
EX-10.1
yrb035g
2 Jun 21
Entry into a Material Definitive Agreement
4:25pm
10-K
a1p7dvs9sc1 yq
17 Mar 21
Annual report
8:33am
8-K
EX-99.1
cdpd1
17 Nov 20
Praxis Precision Medicines Provides Update On PRAX-114 IND Submission
4:01pm
8-K
EX-3.2
bws 8d67l5zt8q8zb
20 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:20pm
424B4
fx0n s34fvxk
16 Oct 20
Prospectus supplement with pricing info
4:02pm